TÜRK, HACI MEHMETTsuboi M.Herbst R. S.John T.Kato T.Majem M.Grohé C.Wang J.Goldman J. W.Lu S.Su W.et al.2023-08-012023-08-012023-07-13Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., Wang J., Goldman J. W., Lu S., Su W., et al., "Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.", The New England journal of medicine, cilt.389, sa.2, ss.137-147, 20230028-4793https://hdl.handle.net/20.500.12645/38493info:eu-repo/semantics/openAccessOverall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.Article10.1056/nejmoa2304594372725351371473892